Syphilis
Treponema pallidum
Profile
The causative agent of syphilis (lues), Treponema(T.) pallidum, is a bacterium that belongs to the spirochete family. Transmission occurs mainly through sexual intercourse. The disease progresses in several stages if untreated and may last for months to years. Spontaneous recovery is possible.
Infection route
Infection usually occurs through sexual contact. Transmission from mother to child is also possible during pregnancy and at birth. Transmission via blood transfusions has been described in isolated cases. Treponemas are highly infectious. In the case of sexual contact with an infected person in stage I or II, the risk of transmission is around 30%.
Symptomatology
The course of a syphilis infection can be divided into four different stages. For details on the individual stages, see the technical information.
Situation in Austria
Since syphilis is not a notifiable disease in Austria, there are no official case figures in this country. An overview of the case numbers in Europe can be found in the annual epidemiological report of the ECDC
Specialized information
Symptomatology
The first phase, primary syphilis, is characterized by the appearance of a mostly painless ulcer with a hardened border. This "ulcus durum" or "hard chancre" usually occurs at the site of infection, i.e. on the penis, vulva or also in the anal region. It is usually accompanied by painless lymphadenitis. The ulcer usually heals with scarring within six weeks.
In the second stage, secondary syphilis, there are general symptoms with swelling of the lymph nodes and flu symptoms as well as a very broad and variable spectrum of skin and mucous membrane symptoms that resolve spontaneously after three to six weeks, even if untreated.
This is followed by a dormant stage (lues latens) in which no symptoms occur despite positive detection of the pathogen.
In about one third of all inadequately treated patients, gummatous, tumor-like tissue changes form in the third stage, tertiary syphilis, which can occur in all organs and secrete an inflammatory secretion when they appear on the skin. In the cardiovascular system, inflammation may occur in the great vessels, especially in the aorta, and also aortic aneurysms. If the central nervous system is affected, the disease is referred to as neurosyphilis. This can already occur in the primary and secondary stages of the disease or as a late manifestation in the fourth stage of syphilis infection (quaternary syphilis).
Quaternary syphilis may be asymptomatic, meaning that no symptoms occur despite evidence of involvement of the nervous system. If the stage is symptomatic, possible manifestations include strokes, sensory and balance disturbances, signs of meningitis, seizures, progressive paralysis, dementia, and personality changes.
A combination of clinical and laboratory diagnostic tests should always be performed to diagnose syphilis.
Therapy
The first-line treatment for syphilis is intramuscular administration of penicillin G. The duration of treatment varies depending on the stage of the disease. The duration of treatment varies depending on the stage: while a single dose is sufficient for early syphilis, three injections spread over 15 days are administered for late syphilis. If neurosyphilis is present, penicillin G should be administered intravenously; the recommended duration of treatment is 14 days.
In case of penicillin allergy, doxycycline or ceftriaxone may be used alternatively.
A frequent complication of therapy is the Jarisch-Herxheimer reaction: here, due to the decay of the pathogen under antibiotic therapy, bacterial endotoxins are released, leading to an uncontrolled immune response and an acute systemic inflammatory reaction. This is manifested by the onset of fever and flu symptoms within a few hours after initiation of therapy. Tachycardia, rise or fall in blood pressure, seizures and other symptoms may occur. Glucocorticoids can be used for drug therapy, although these should be administered prophylactically from the secondary stage onwards.
Diagnostics
Dark-field microscopy is suitable for the direct detection of the pathogen from primary genital lesions or from weeping lesions in the secondary stage. Molecular biological methods such as PCR may be used, particularly where there is clinical suspicion of an early primary lesion. However, a negative result from these diagnostic procedures does not definitively rule out syphilis.
In practice, purely serological tests for the detection of antibodies are generally used. ELISA/EIA (enzyme-linked immunosorbent assay), CLIA/CMIA (chemiluminescent (microparticle) immunoassay) or; TPHA (Treponema pallidum haemagglutination assay) serve as pathogen-specific screening tests for syphilis infection. The tests become positive 2–3 weeks after infection and usually remain so for life. A negative test result after the end of the incubation period (2–3 weeks) largely rules out infection. If a treponema-specific screening test yields a positive or borderline result, confirmation is carried out using a second, independent treponema-specific method.
To confirm a positive or equivocal screening test, the Treponema pallidum Antibody Absorption Test (FTA-ABS) is carried out (= confirmatory test). If an ELISA is used as the screening test, confirmation by means of a TPHA test is also possible, and vice versa. If the confirmatory test is negative, a syphilis infection is considered unlikely. If the test is positive, this suggests syphilis requiring treatment or a past or previously treated infection (‘seronarbe’). To distinguish between these, a quantitative determination of activity parameters must be carried out.
To determine disease activity, a quantitative T. pallidum-specific IgM antibody test, an RPR (Rapid Plasma Reagin) test or a VDRL (Venereal Disease Research Laboratory) test may be carried out. IgM antibodies can be detected as early as one to two weeks after infection and should no longer be detectable within six to twelve months of starting treatment. The RPR and VDRL tests only yield positive results after four to six weeks; a declining titre during treatment suggests that the treatment is successful, although the antibodies may persist for life.
If syphilis is present, further diagnostic tests should be offered to rule out other sexually transmitted infections.
Last updated: 23.07.2026
automatically translated